New PET scan method could better track brain tumor treatment success
NCT ID NCT07017790
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special type of PET scan (amino acid PET) can better measure how well IDH inhibitor drugs are working in patients with a certain type of brain tumor (IDH-mutated glioma). The researchers compared the PET scan results with standard MRI scans in 22 patients. The goal was to see if the PET scan could detect treatment response earlier or more accurately than MRI.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18-fluoroDopa (amino acid PET tracer)
What this could lead to
If successful, this could establish amino acid PET as a more accurate way to assess whether IDH inhibitor treatments are working in patients with IDH-mutated gliomas.
What could go wrong
This is a small, completed observational study with only 22 patients. It does not test a new treatment itself, so any benefits are limited to improving how we measure response, not directly improving outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU of NANCY
Vandœuvre-lès-Nancy, 54511, France